In the early 2000s, when hyaluronic acid was a niche medical product priced at $10,000 per kilogram, Zhao Yan saw an opportunity to democratize its use through science. Today, as founder of Bloomage Biotechnology, she leads a global biotech powerhouse that produces over 40% of the world's hyaluronic acid supply — now widely used in skincare and wellness products.
Zhao's journey began in 2001 with a bold bet on microbial fermentation technology. Her team's breakthrough reduced production costs by 95%, transforming the compound from a luxury medical resource into a $100 billion global industry cornerstone. Under her leadership, Bloomage has expanded into synthetic biology and regenerative medicine, holding 136 domestic patents and 69 international ones.
What sets Bloomage apart? A research team where women constitute 60% of members, challenging tech industry norms. 'Diverse perspectives fuel disruptive innovation,' Zhao notes, emphasizing her commitment to gender parity in STEM fields.
Beyond the lab, Zhao champions cultural preservation through initiatives like the Cloud Project, which combines biotechnology with traditional Chinese medicine practices. The company's circular production model recycles 98% of water used in manufacturing, aligning with China's carbon neutrality goals.
